HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,809 | +0.9% | 11,173 | -4.7% | 0.01% | +18.2% |
| Q2 2023 | $423,101 | -10.0% | 11,730 | -4.7% | 0.01% | -15.4% |
| Q1 2023 | $470,272 | -33.5% | 12,314 | -0.9% | 0.01% | -35.0% |
| Q4 2022 | $706,983 | +42.5% | 12,425 | -0.9% | 0.02% | +33.3% |
| Q3 2022 | $496,000 | -10.0% | 12,532 | 0.0% | 0.02% | +15.4% |
| Q2 2022 | $551,000 | +9.3% | 12,532 | -0.8% | 0.01% | +30.0% |
| Q1 2022 | $504,000 | -0.6% | 12,632 | +0.2% | 0.01% | +11.1% |
| Q4 2021 | $507,000 | -2.3% | 12,609 | -1.2% | 0.01% | -18.2% |
| Q3 2021 | $519,000 | -7.2% | 12,764 | +3.8% | 0.01% | 0.0% |
| Q2 2021 | $559,000 | +12.2% | 12,300 | +3.0% | 0.01% | 0.0% |
| Q1 2021 | $498,000 | -3.1% | 11,945 | -0.8% | 0.01% | -8.3% |
| Q4 2020 | $514,000 | – | 12,045 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |